InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Browse the complete record of transactions filed by Brazzell Romulus K, Directeur Médical. Officer active across 1 companies, notably Kala Pharmaceuticals, Inc.. Aggregated, 7 disclosures have been logged. Total volume traded: €78k. The latest transaction was filed on 27 June 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
€1,0993,144 shares@ €0.34970.0071% mcap1.4% of flow
Common Stock
SEC:0001415889-22-007061:0·
€4,0303,504 shares@ €1.150210.5% of flow
Common Stock
SEC:0001415889-22-000404·
€4,0303,504 shares@ €1.15020.026% mcap5.2% of flow
Common Stock
SEC:0001415889-22-000404:0·
€19,79812,757 shares@ €1.55251.4% of flow
Common Stock
SEC:0001415889-21-005010·
€19,79812,757 shares@ €1.5520.13% mcap25.3% of flow
Common Stock
SEC:0001415889-21-005010:0·
€14,6753,034 shares@ €4.83738.1% of flow
Common Stock
SEC:0001415889-21-003258·
€14,6753,034 shares@ €4.8370.095% mcap18.8% of flow
Common Stock
SEC:0001415889-21-003258:0·
7 of 7 declarations
About Brazzell Romulus K
Romulus K. Brazzell is the Chief Medical Officer at Kala Pharmaceuticals, Inc. He is responsible for the company's medical direction, overseeing clinical and research activities. His expertise is essential for the development of new treatments.
